BPC-157

BPC-157

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide consisting of a stable chain of 15 amino acids, structurally derived from a partial sequence of a naturally occurring gastric protective protein. Extensively studied within molecular biology and cellular signaling networks, BPC-157 serves as a crucial signaling-active reference peptide in laboratory models evaluating cellular communication, tissue-protective cascades, and extracellular matrix remodeling. Researchers utilize this compound in controlled in vitro frameworks to analyze its localized regulatory role without confounding systemic biological interferences.

Technical Specifications

Research Applications & Mechanism of Interest

In advanced laboratory testing, BPC-157 provides an essential core baseline for monitoring how specific peptide architectures interface with intracellular messaging loops. Research published in prominent vascular biology and molecular medicine journals documents its proposed interaction with growth factor receptors and nitric oxide synthesis pathways, rendering it highly relevant for cell growth, structural migration, and tissue-protective studies.

Primary investigative workflows include:

• Cell Migration Assays: Tracking and mapping cell movement, directional velocity, and recruitment patterns within isolated cellular models.

• Angiogenesis Modeling: Examining endothelial cell culture lineages to observe how the specific peptide sequence modulates vascular endothelial growth factor receptor 2 (VEGFR2) expressions and downstream signaling cascades.

• Growth Factor Interactions: Investigating modulating effects on baseline fibroblastic growth factors and early response gene expressions during structural communication.

• In Vitro Wound Modeling: Exploring cellular signaling thresholds, cell survival under induced oxidative stress, and scratch assay protocol compliance.

• Receptor Interaction Mapping: Deploying competitive binding assays to map specific binding partners, structural tolerance thresholds, and molecular footprints across tissue models.

Storage & Handling Guidelines

To prevent premature degradation of the peptide bonds and ensure absolute baseline reproducibility across analytical workflows, adhere to the following protocols:

• Thermal Regulation: For long-term chemical preservation, maintain the compound under deeply frozen conditions (-20°C or lower). For short-term experimental deployment, ambient or standard cool parameters are sufficient if completely protected from thermal spikes.

• Atmospheric Separation: Store the target chemical exclusively inside its original, tightly sealed containment unit, completely isolated from ambient humidity, moisture, and localized airflow.

• Photolytic Barriers: Protect the compound from direct light and UV exposure by keeping it inside opaque or amber laboratory vessels.

• Analytical Auditing: Kimera Chems implements a strict dual-method verification protocol, combining High-Performance Liquid Chromatography (HPLC) with CHN elemental analysis to independently audit the net mass and absolute purity of our research compounds.

Research Use Only Disclaimer: This product is distributed and sold strictly as a Research Use Only (RUO) compound intended exclusively for in vitro laboratory evaluation and academic investigation. It is not an FDA-approved drug, licensed medication, dietary supplement, or cosmetic agent, and is strictly prohibited for human or veterinary consumption. Improper use of laboratory reference materials can present significant biological hazards. Kimera Chems supplies these materials exclusively to qualified scientific institutions and professional investigators.

Scientific References

1. Chang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., & Pang, J. H. (2011). “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” Journal of Applied Physiology, 110(3), 774–780. DOI: 10.1152/japplphysiol.00945.2010.

2. Hsieh, C. H., et al. (2017). “Pentadecapeptide BPC 157 enhances endothelial cell migration and angiogenesis via VEGFR2 activation.” Journal of Molecular Medicine, 95(3), 323-333. DOI: 10.1007/s00109-016-1488-y.

3. He, L., Feng, D., Guo, H., et al. (2022). “Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.” Frontiers in Pharmacology, 13, 1026182. DOI: 10.3389/fphar.2022.1026182.